SEOM clinical guideline on unknown primary cancer (2017)

• F. Losa ^[1] ; G. Soler ^[2] ; A. Casado ^[3] ; A. Estival ^[4] ; I. Fernández ^[5] ; S. Giménez ^[10] ; F. Longo ^[6] ; R. Pazo-Cid ^[7] ; J. Salgado ^[8] ; M. Á. Seguí ^[9]
  1. [1] Hospital de Sant Joan Despí Moisès Broggi

     Hospital de Sant Joan Despí Moisès Broggi

     Barcelona, España

     
  2. [2] Hospital Duran i Reynals

     Hospital Duran i Reynals

     Barcelona, España

     
  3. [3] Hospital Clínico San Carlos de Madrid

     Hospital Clínico San Carlos de Madrid

     Madrid, España

     
  4. [4] Hospital Universitari Germans Trias i Pujol

     Hospital Universitari Germans Trias i Pujol

     Barcelona, España

     
  5. [5] Hospital Álvaro Cunqueiro

     Hospital Álvaro Cunqueiro

     Vigo, España

     
  6. [6] Hospital Ramón y Cajal

     Hospital Ramón y Cajal

     Madrid, España

     
  7. [7] Hospital Miguel Servet

     Hospital Miguel Servet

     Zaragoza, España

     
  8. [8] Gobierno de Navarra

     Gobierno de Navarra

     Pamplona, España

     
  9. [9] Corporació Sanitària Parc Taulí

     Corporació Sanitària Parc Taulí

     Barcelona, España

     
  10. [10] Hospital Universitari I Politècnic la Fe, España

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 20, Nº. 1 (January 2018), 2018, págs. 89-96
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Cancer of unknown primary site is a histologically confirmed cancer that manifests in advanced stage, with no identifiable primary site following standard diagnostic procedures. Patients are initially categorized based on the findings of the initial biopsy: adenocarcinoma, squamous-cell carcinoma, neuroendocrine carcinoma, and poorly differentiated carcinoma. Appropriate patient management requires understanding several clinical and pathological features that aid in identifying several subsets of patients with more responsive tumors.